Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical Research

BSE Live

Apr 20, 16:01
144.45 -3.45 (-2.33%)
Volume
AVERAGE VOLUME
5-Day
96,945
10-Day
126,207
30-Day
101,022
33,692
  • Prev. Close

    147.90

  • Open Price

    150.65

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 20, 15:58
144.50 -3.51 (-2.37%)
Volume
AVERAGE VOLUME
5-Day
1,461,208
10-Day
2,438,787
30-Day
2,077,632
569,428
  • Prev. Close

    148.01

  • Open Price

    148.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    144.50 (1153)

Financials

Balance Sheet of Sun Pharma Advanced Research Company (in Rs. Cr.) Mar 25 Mar 24 Mar 23  
  12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 32.45 32.45 32.45  
Total Share Capital 32.45 32.45 32.45  
Reserves and Surplus -249.40 93.30 480.32  
Total Reserves and Surplus -249.40 93.30 480.32  
Total Shareholders Funds -216.95 125.76 512.78  
Minority Interest 0.00 0.00 0.00  
NON-CURRENT LIABILITIES  
Long Term Borrowings 100.00 0.00 0.00  
Deferred Tax Liabilities [Net] 0.00 0.00 0.00  
Other Long Term Liabilities 70.57 118.18 130.27  
Long Term Provisions 7.68 6.05 8.14  
Total Non-Current Liabilities 178.24 124.23 138.41  
CURRENT LIABILITIES  
Short Term Borrowings 158.19 47.00 0.05  
Trade Payables 113.92 142.29 148.25  
Other Current Liabilities 94.69 63.52 24.15  
Short Term Provisions 7.45 12.24 6.49  
Total Current Liabilities 374.24 265.06 178.95  
Total Capital And Liabilities 335.53 515.04 830.13  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 98.69 107.35 105.41  
Intangible Assets 0.06 0.19 0.34  
Capital Work-In-Progress 0.56 1.27 1.87  
Fixed Assets 152.91 151.33 132.75  
Non-Current Investments 0.00 0.00 0.00  
Deferred Tax Assets [Net] 2.31 1.26 0.00  
Long Term Loans And Advances 0.00 0.00 0.00  
Other Non-Current Assets 154.12 93.07 242.41  
Total Non-Current Assets 309.34 245.66 375.16  
CURRENT ASSETS  
Current Investments 0.00 1.80 290.90  
Inventories 0.00 0.00 0.00  
Trade Receivables 16.06 15.53 32.71  
Cash And Cash Equivalents 1.96 155.33 111.58  
Short Term Loans And Advances 0.16 0.22 0.54  
OtherCurrentAssets 8.01 96.50 19.23  
Total Current Assets 26.20 269.39 454.96  
Total Assets 335.53 515.04 830.13  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 407.82 420.56 343.46  
BONUS DETAILS  
Bonus Equity Share Capital 0.00 0.00 0.00  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value 0.00 0.00 0.00  
Non-Current Investments Unquoted Book Value 0.00 0.00 0.00  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value 0.00 0.00 0.00  
Current Investments Unquoted Book Value 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347